Close

Publications

Gordon, SB; Chaponda, M; Walsh, AL; WHITTY, CJ M; Gordon, MA; Machili, CE; Gilks, CF; Boeree, MJ; Kampondeni, S; Read, RC; Molyneux, ME;
2002
AIDS (London, England), (2002).16 10 10.1097/00002030-200207050-00013.
Costing the implementation of the change in first-line drug for malaria treatment in Tanzania.
MILLS, A; Mulligan, J; Mandike, R; Palmer, N; Holly, WA; S, A; Bloland, P;
2002
Multilateral Initiative on Malaria African Malaria Conference (2002).
Muriithi, MW; Abraham, W-R; Addae-Kyereme, J; Scowen, I; CROFT, SL; Gitu, PM; Kendrick, H; Njagi, EN M; Wright, CW;
2002
Journal of natural products, (2002).65 7 10.1021/np0106182.
Modelling the cost effectiveness of combination therapy and drug resistance.
MILLS, A; YEUNG, S; Pongtavornpinyo, W; Hastings, I; White, N;
2002
Multilateral Initiative on Malaria African Malaria Conference (2002).
Hammerich, A; CAMPBELL, OM R; CHANDRAMOHAN, D;
2002
Tropical medicine & international health, (2002).7 7 10.1046/j.1365-3156.2002.00898.x.
Dorsey, G; Njama, D; Kamya, MR; Cattamanchi, A; Kyabayinze, D; STAEDKE, SG; Gasasira, A; Rosenthal, PJ;
2002
Lancet, (2002).360 9350 10.1016/S0140-6736(02)12021-6.
Big risk? Malaria among pregnant women in low transmission areas.
Hammerich, A; CAMPBELL, O; CHANDRAMOHAN, D;
2002
id21 Health Highlights (2002).
Huillard d'Aignaux, JN; COUSENS, SN; Maccario, J; Costagliola, D; Alpers, MP; SMITH, PG; Alpérovitch, A;
2002
Epidemiology (Cambridge, Mass), (2002).13 4 10.1097/00001648-200207000-00007.